Back to Journals » OncoTargets and Therapy » Volume 10

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers

Total article views   HTML views PDF downloads Totals
18,034 Dovepress* 12,984+ 2,116 15,100
PubMed Central* 5,050 1,293 6,343
Totals 18,034 3,409 21,443
*Since 6 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed Central and Google Scholar